Synopsys, Inc. (ETR:SYP)

Sage Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is November - October.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Market Capitalization	98,694	72,665	67,575	45,240	43,941	27,850
Market Cap Growth	-17.36%	7.53%	49.37%	2.96%	57.78%	52.17%
Enterprise Value	95,666	71,482	66,530	44,416	43,204	27,532
Last Close Price	529.50	490.75	443.80	297.25	277.70	188.40
PE Ratio	51.76	34.86	58.05	45.43	67.08	48.85
PS Ratio	18.00	12.88	13.43	9.69	12.09	8.81
PB Ratio	11.29	8.74	11.54	8.05	9.59	6.61
P/TBV Ratio	17.83	14.76	27.87	34.76	35.28	25.20
P/FCF Ratio	-	61.45	47.17	27.92	36.32	38.80
P/OCF Ratio	-	56.07	41.92	25.73	34.04	32.74
EV/Sales Ratio	17.88	12.67	13.22	9.52	11.88	8.71
EV/EBITDA Ratio	69.67	50.20	46.07	32.70	54.20	39.39
EV/EBIT Ratio	85.64	57.25	53.00	37.86	65.03	48.90
EV/FCF Ratio	100.00	60.45	46.44	27.41	35.71	38.35
Debt / Equity Ratio	1.08	0.08	0.11	0.12	0.13	0.14
Debt / EBITDA Ratio	6.73	0.41	0.41	0.46	0.65	0.73
Debt / FCF Ratio	9.90	0.53	0.45	0.41	0.48	0.79
Asset Turnover	0.36	0.52	0.54	0.51	0.50	0.51
Inventory Turnover	2.99	3.31	3.67	3.87	3.86	4.45
Quick Ratio	6.72	1.88	0.82	0.95	1.01	1.06
Current Ratio	7.02	2.44	1.15	1.09	1.16	1.19
Return on Equity (ROE)	15.55%	18.60%	20.70%	17.76%	14.81%	14.74%
Return on Assets (ROA)	4.67%	7.24%	8.39%	7.98%	5.72%	5.68%
Return on Capital (ROIC)	5.70%	10.23%	12.68%	11.90%	8.32%	8.37%
Return on Capital Employed (ROCE)	6.10%	13.00%	18.10%	17.50%	12.10%	11.10%
Earnings Yield	1.93%	2.87%	1.72%	2.20%	1.49%	2.05%
FCF Yield	0.97%	1.63%	2.12%	3.58%	2.75%	2.58%
Buyback Yield / Dilution	-0.50%	-0.48%	0.82%	0.54%	-1.05%	-0.98%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.